Kerry A. Casey, Ph.D.
Affiliations: | 2009 | Microbiology, Immunology and Cancer Biology | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
ImmunologyGoogle:
"Kerry Casey"Mean distance: 6635.5
Parents
Sign in to add mentor| Matthew F. Mescher | grad student | 2009 | UMN | |
| (Third signal cytokines and their roles in CD8 T cell responses.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Smith MA, Chiang CC, Zerrouki K, et al. (2020) Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus. Scientific Reports. 10: 4462 |
| Nicholson SM, Casey KA, Gunsior M, et al. (2019) The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeys. British Journal of Pharmacology |
| Rahman S, Sagar D, Hanna RN, et al. (2019) Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus. Annals of the Rheumatic Diseases |
| Hudspeth K, Wang S, Wang J, et al. (2019) Natural Killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in Systemic Lupus Erythematosus. Clinical and Experimental Immunology |
| Varkey R, Du Q, Karnell JL, et al. (2019) Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy. Plos One. 14: e0211236 |
| Casey KA, Guo X, Smith MA, et al. (2018) Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE. Lupus Science & Medicine. 5: e000286 |
| Gerner MY, Casey KA, Kastenmuller W, et al. (2017) Dendritic cell and antigen dispersal landscapes regulate T cell immunity. The Journal of Experimental Medicine |
| White W, Casey K, Smith M, et al. (2017) SAT0220 Effects of type I interferon inhibition on blood leukocyte subsets in patients treated in a phase IIB clinical study of anifrolumab in systemic lupus erythematosus (SLE) Annals of the Rheumatic Diseases. 76: 856-857 |
| Beura LK, Hamilton SE, Bi K, et al. (2016) Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature |
| Schenkel JM, Fraser KA, Casey KA, et al. (2016) IL-15-Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells. Journal of Immunology (Baltimore, Md. : 1950) |